National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$59.95
add to cart

Rights & Permissions

topleft topright

Dietary Supplements: A Framework for Evaluating Safety (2005)
Institute of Medicine (IOM)

Citation Manager

. "Appendix H: Saw Palmetto: Prototype Monograph Summary." Dietary Supplements: A Framework for Evaluating Safety. Washington, DC: The National Academies Press, 2005.

Please select a format:

BibTeX EndNote RefMan


Page
378
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Dietary Supplements: A Framework for Evaluating Safety

none are recognized as toxic substances. Likewise, the plant family, Arecaceae, is not generally regarded as a toxic plant family.

Based on the limited in vitro studies to date, functionally related substances might include drugs that are inhibitors of steroid 5-α-reductase or antagonists of α1-adrenergic receptors. In general, these drugs are contraindicated for women and children (GlaxoSmithKline, 2001; Thomson PDR, 2004). Pregnant women are even cautioned not to touch broken tablets containing inhibitors of steroid 5-α-reductase (GlaxoSmithKline, 2001; Thomson PDR, 2004). Concern with these drugs are that in utero effects of inhibiting testosterone synthesis or action can deleteriously affect the external genitalia and internal reproductive organs of a male fetus (Bowman et al., 2003; Clark et al., 1990, 1993; GlaxoSmithKline, 2001).

B. Conclusions and Recommendations About the Safety of the Ingredient Based on the Strength of the Scientific Evidence

At the present time, the weight of the scientific evidence does not suggest that the consumption of saw palmetto powdered fruit or fruit extracts poses a safety risk when consumed by men at the currently recommended doses. These conclusions are germane only to the fruit and fruit extracts presently used; introduction of new products involving different plant parts would warrant further scrutiny.

However, unlike for men, the reported adverse side effects for drugs that inhibit steroid 5-α-reductase or antagonize α1-adrenergic receptors raise concern about women who may become pregnant while using saw palmetto. This concern is mitigated somewhat by the apparent popularity of saw palmetto with men rather than women, but as noted, saw palmetto use is not limited to men. It is not evident that the testosterone pathway effects raise concerns about the safe use of saw palmetto fruit or fruit extracts in men.

C. Unresolved Issues and Uncertainties in the Available Data

  • Additional phytochemical analyses of the fruit and, especially, of the various fruit extracts (in which minor components would be expected to be concentrated) are needed in order to determine the presence of biologically active chemical components.

  • In vitro reports of cytotoxicity in prostate cancer cell lines have not been extended to other cell types in order to ascertain whether there is broader cytotoxicity.

Page
378
Front Matter (R1-R20)
Executive Summary (1-18)
1 Introduction and Background (19-42)
2 Approaches Used by Others and Existing Safety Frameworks (43-84)
3 The Framework (85-125)
4 Categories of Scientific Evidence--Human Information and Data (126-155)
5 Categories of Scientific Evidence--Animal Data (156-174)
6 Categories of Scientific Evidence--Information About Related Substances (175-216)
7 Categories of Scientific Evidence--In Vitro Data (217-234)
8 Interactions (235-246)
9 Vulnerable Groups and Prevalance of Use (247-252)
10 Scientific Principles for Integrating and Evaluating the Available Data (253-268)
11 Applying the Framework: Case Studies Using the Prototype Safety Monographs (269-291)
12 Factors Influencing Use of the Safety Framework (292-296)
13 Findings and Recommendations (297-306)
Appendix A: Existing Frameworks or Systems for Evaluating the Safety of Other Substances (307-315)
Appendix B: Scope of Work and Comments to Initial July 2002 Framework (316-321)
Appendix C: Plant Family Information (322-355)
Appendix D: Chaparral: Prototype Monograph Summary (356-362)
Appendix E: Glucosamine: Prototype Monograph Summary (363-366)
Appendix F: Melatonin: Prototype Monograph Summary (367-371)
Appendix G: Chromium Picolinate: Prototype Monograph Summary (372-375)
Appendix H: Saw Palmetto: Prototype Monograph Summary (376-379)
Appendix I: Shark Cartilage: Prototype Monograph Summary (380-384)
Appendix J: Prototype Focused Monograph: Review of Liver-Related Risks for Chaparral (385-449)
Appendix K: Protoype Focused Monograph: Review of Anti-Androgenic Risks of Saw Palmetto Ingestion by Women (450-477)
Appendix L: Acknowledgements (478-480)
Appendix M: Biographical Sketches of Commitee Members (481-488)
Index (489-506)